Myla Lai-Goldman
InvestorVenture Partner at Hatteras Venture Partners
Burlington, Vermont
Writes $100K β $5M checks Β· typically $1.5M
About
Myla Lai-Goldman is Chair and Co-Founder of GeneCentric Therapeutics, Inc. and serves as a Board Member at Mercy BioAnalytics, Inc. She spent over 18 years at LabCorp, including 10 years as Executive Vice President, Chief Medical Officer and Chief Scientific Officer, where she oversaw three genomic laboratories and led the introduction of more than 400 clinical assays. She holds a BS from the University of Pennsylvania and an MD from Columbia University College of Physicians and Surgeons, and is board-certified in anatomic and clinical pathology.
Experience
- Mercy BioAnalytics, Inc.Board Membercurrent2023 β present
- NovoPathBoard Membercurrent2022 β present
- GeneCentric Therapeutics, Inc.Co-Founder and Chaircurrent2021 β present
- GeneCentric Therapeutics, Inc.Executive Chair2019 β 2021Research Triangle Park, NC
- GeneCentric Therapeutics, Inc.Chief Executive Officer2011 β 2018280 S. Mangum Street Suite 350 Durham, NC 27701
- West Pharmaceutical ServicesBoard Membercurrent2014 β present
- Hatteras Venture PartnersVenture Partnercurrent2011 β present280 S Mangum St, Suite 350 Durham, NC 27701
- Personalized Science, LLCManaging Partnercurrent2009 β presentS Burlington, Vermont
- QuanterixBoard Member2025 β 2026
- Hitachi High-Tech America, Inc.Scientific Advisory Board Member2023 β 2026
- Akoya Biosciences, Inc.Board Member2021 β 2025
- LabCorpExecutive VP, CMO & CSO1998 β 2008128 East Maple Avenue, Burlington, NC 27215
- LabCorpPathologist, VP, SVP1990 β 1998
Education
- Columbia University Vagelos College of Physicians and SurgeonsDoctor of Medicine (MD)1979 β 1983
- University of PennsylvaniaBachelor of Arts (B.A.), Biology1975 β 1979
Skills & more
+12 more
Molecular BiologyClinical DevelopmentDrug DevelopmentTechnology TransferDrug DiscoveryPharmaceutical IndustryBiopharmaceuticalsHealthcareGeneticsBiochemistryMedical DevicesClinical TrialsFrom Myla's professional profile.
Same school
Also attended Columbia University Vagelos College of Physicians and Surgeons13
+ 7 more
Also attended University of Pennsylvania607
+ 601 more
Shared employers
Also worked at Akoya Biosciences, Inc.3
Deals Β· 1
Genecentric TherapeuticsBoard seat
via Hatteras Venture Partners Β· filed Jun 2025 Β· $5M raise
Attribution from SEC filings, press coverage, and firm rosters.

























